Literature DB >> 10665756

Cancer of the mobile tongue in Finland--increasing incidence, but improved survival.

O P Alho1, S Kantola, U Pirkola, E Läärä, K Jokinen, E Pukkala.   

Abstract

A population-based descriptive study was conducted to describe incidence and survival of cancer of the mobile tongue in Finland between 1953 and 1994. The study included 1504 patients, drawn from the Finnish Cancer Registry, with first primary mobile tongue cancer diagnosed between 1953 and 1994. Incidence and relative survival were determined. The age-standardized overall incidence rate was 0.6 per 100000 years in 1953-1994. At the time of diagnosis 78% of the patients had either localized or regional disease. The age-standardized incidence rate decreased after the mid-1960s, but increased in the 1990s. The 5-year relative survival rate increased gradually from 40% in 1953 1959 to 58% in 1988-1994. Disease stage at the time of the diagnosis strongly affected the survival rate. Survival increased especially in regional disease. Cancer of the mobile tongue is increasing in Finland, but survival has increased particularly in regional disease, probably because of improved treatment. Early diagnosis is emphasized for a good prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10665756     DOI: 10.1080/028418699432293

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Oral tongue carcinoma and its treatment in Finland.

Authors:  Antti A Mäkitie; Petri Koivunen; Harri Keski-Säntti; Jyrki Törnwall; Matti Pukkila; Jussi Laranne; Marjaana Luukkaa; Jyrki Vuola; Timo Joensuu; Mikael Kajanti; Reidar Grénman
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-21       Impact factor: 2.503

2.  The prognostic role of phospho-Src family kinase analysis in tongue cancer.

Authors:  Ofer Ben-Izhak; Victoria Cohen-Kaplan; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

3.  Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.

Authors:  J T Korpi; V Kervinen; H Mäklin; A Väänänen; M Lahtinen; E Läärä; A Ristimäki; G Thomas; M Ylipalosaari; P Aström; C Lopez-Otin; T Sorsa; S Kantola; E Pirilä; T Salo
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

4.  Oral tongue cancer in public hospitals in Madrid, Spain (1990-2008).

Authors:  A-I García-Kass; A Herrero-Sánchez; G Esparza-Gómez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.